Qhslab, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB
QHSLab delivered 26% revenue growth, positive net income, and eliminated over $1.4M of defaulted convertibles via repurchase, while warning of going-concern risks and material control weaknesses.
OQB
QHSLab, Inc.'s annual report reveals revenue growth driven by allergy diagnostic kits and integrated service programs, but also highlights significant debt and uncertainties about the company's ability to continue as a going concern.
OQB
QHSLab, Inc. reported a net loss for 2023 and highlighted ongoing concerns about its ability to continue as a going concern.